Everything below concerns synthetic peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-09-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from a fragment of human growth hormone |
| Sequence basis | hGH residues 176-191 | Commonly described as a 16-amino-acid fragment |
| Appearance | White to off-white powder | Typical for lyophilized research peptides |
| Solubility | Soluble in water or aqueous buffer | Exact solubility depends on pH and purity |
| Common synonyms | AOD9604; hGH 176-191 | Spelling and punctuation vary across sources |
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
==== Insulet: Omnipod 5 ==== The first tubeless automated insulin delivery system, Omnipod 5 uses SmartAdjust technology to actively predict glucose levels up to 60 minutes ahead and adjust insulin delivery every 5 minutes—automatically increasing, decreasing, or pausing basal insulin—towards a user‑customizable glucose target. The system integrates with several continuous glucose monitors: Dexcom G6, Dexcom G7, and Freestyle Libre 2 Plus. Omnipod 5 is FDA‑cleared for people with type 1 diabetes aged 2 years and older, and adults with type 2 diabetes aged 18+. The Omnipod 5 became available through the NHS in the UK in 2023 in limited areas, and in 2024 the NHS announced the gradual rollout of Hybrid Closed Loop systems to all type 1 diabetes patients in England over the next 5 years, including the Omnipod 5.
Strained cyclooctenes and other activated alkenes react with tetrazines in an inverse electron-demand Diels-Alder reaction followed by a retro [4+2] cycloaddition (see figure). Three-membered and four-membered cycloalkenes, due to their high ring strain, also make ideal alkene substrates. Similar to other [4+2] cycloadditions, electron-donating substituents on the dienophile and electron-withdrawing substituents on the diene accelerate the inverse-demand Diels-Alder reaction. The diene, the tetrazine, by virtue of having the additional nitrogens, is a good diene for this reaction. The dienophile, the activated alkene, may often be attached to electron-donating alkyl groups on target molecules, thus making the dienophile more suitable for the reaction.
== Further reading == A, Graziano; F, Bianco; A, D'Amico; I, Moroni; S, Messina; C, Bruno; E, Pegoraro; M, Mora; G, Astrea (2015-03-01). "Prevalence of congenital muscular dystrophy in Italy: a population study". Neurology. 84 (9): 904–911. doi:10.1212/WNL.0000000000001303. ISSN 0028-3878. PMC 4351663. PMID 25653289. Paco, Sonia; Casserras, Teresa; Rodríguez, Maria Angels; Jou, Cristina; Puigdelloses, Montserrat; Ortez, Carlos I.; Diaz-Manera, Jordi; Gallardo, Eduardo; Colomer, Jaume (2015-12-15). "Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators". PLOS ONE. 10 (12) e0145107. Bibcode:2015PLoSO..1045107P. doi:10.1371/journal.pone.0145107. ISSN 1932-6203. PMC 4686057. PMID 26670220. Falsaperla, Raffaele; Praticò, Andrea D.; Ruggieri, Martino; Parano, Enrico; Rizzo, Renata; Corsello, Giovanni; Vitaliti, Giovanna; Pavone, Piero (31 August 2016). "Congenital muscular dystrophy: from muscle to brain". Italian Journal of Pediatrics. 42 (1): 78. doi:10.1186/s13052-016-0289-9. ISSN 1824-7288. PMC 5006267. PMID 27576556. "Summary of Evidence-based Guideline for PATIENTS and their FAMILIES CONGENITAL MUSCULAR DYSTROPHY". aaan.com. The American Academy of Neurology (AAN). Retrieved 5 December 2017.
Sources: en.wikipedia.org
Phylum Chordata Subphylum Cephalochordata (Acraniata) – (lancelets; 32 species) Class Leptocardii (lancelets) Subphylum Tunicata (Urochordata) – (tunicates; 3,000 species) Class "Ascidiacea" (sea squirts; paraphyletic as thaliaceans are excluded) Class Thaliacea (salps, doliolids and pyrosomes) Class Appendicularia (larvaceans) Subphylum Vertebrata (Craniata) (vertebrates – animals with backbones; 66,100+ species) Infraphylum "Agnatha" paraphyletic (jawless vertebrates; 100+ species) Superclass Cyclostomata Class Myxinoidea or Myxini (hagfish; 85 species) Class Petromyzontida or Hyperoartia (lampreys; 53 species) Class †Conodonta Class †Myllokunmingiida Class †Pteraspidomorphi Class †Thelodonti Class †Anaspida Class †Cephalaspidomorphi Infraphylum Gnathostomata (jawed vertebrates) Class †"Placodermi" (Paleozoic armoured forms; paraphyletic in relation to all other gnathostomes) Class Chondrichthyes (cartilaginous fish; 900+ species) Class †"Acanthodii" (Paleozoic "spiny sharks"; paraphyletic in relation to Chondrichthyes) Class "Osteichthyes" (bony fish; 30,000+ species; paraphyletic when tetrapods are excluded) Subclass Actinopterygii (ray-finned fish; about 30,000 species) Clade "Sarcopterygii" (35,100+ species; paraphyletic when tetrapods are excluded – 8 species of lobe-finned fish) Class Actinistia (2 species) Class Dipnoi (6 species) Superclass Tetrapoda (four-limbed vertebrates; 35,100+ species) Class Amphibia (amphibians; 8,100+ species) Class Sauropsida (reptiles (including birds); 21,300+ species – 10,000+ species of birds and 11,300+ species of reptiles) Class Synapsida (mammals; 5,700+ species) Genus †Cathaymyrus Genus †Pikaia
Industry Secretary Tony Benn thought Heseltine intellectually shallow (describing one of his speeches as "an awful old flop" and another as "another flayling attack") but admired his ability to make headlines in opposition. The infamous mace incident took place on 27 May 1976 during the Labour government Aircraft and Shipbuilding Industries Bill to nationalise those industries, this measure had already lasted a year and seen 58 Committee sessions. The Speaker had ruled the bill to be hybrid, as it excluded one shipbuilding company (although there was dispute as to whether the company in question actually was a shipbuilder). All interested parties were therefore entitled to put their case to a special select committee. An earlier vote in favour of the Speaker's ruling had been tied, and defeated after the Speaker had been obliged by convention to use his casting vote against his own ruling. The Labour Government now moved to suspend the normal Parliamentary standing order to allow the bill to proceed as normal. This time the Conservatives expected the Speaker to use his casting vote against the government's motion to suspend the standing order. Instead the Labour motion was carried, after a Labour whip broke his pair. Amid riotous scenes of Labour left-wingers singing The Red Flag Heseltine picked up the Mace, the symbol of Parliament's authority, until Jim Prior grabbed it off him.
The three substrates of this enzyme are benzaldehyde, oxidised nicotinamide adenine dinucleotide (NAD+), and water. Its products are benzoic acid, reduced NADH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the aldehyde or oxo group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is benzaldehyde:NAD+ oxidoreductase. Other names in common use include benzaldehyde (NAD+) dehydrogenase, and benzaldehyde dehydrogenase (NAD+). This enzyme participates in benzoate degradation via hydroxylation and toluene and xylene degradation.
=== Effects of Temperature === All enzymes work within a range of temperature specific to the organism. Increases in temperature generally lead to increases in reaction rates. There is a limit to the increase because higher temperatures lead to a sharp decrease in reaction rates. This is due to the denaturating (alteration) of protein structure resulting from the breakdown of the weak ionic and hydrogen bonding that stabilize the three-dimensional structure of the enzyme active site. The "optimum" temperature for human enzymes is usually between 35 and 40 °C. The average temperature for humans is 37 °C. Human enzymes start to denature quickly at temperatures above 40 °C. Enzymes from thermophilic archaea found in the hot springs are stable up to 100 °C. However, the idea of an "optimum" rate of an enzyme reaction is misleading, as the rate observed at any temperature is the product of two rates, the reaction rate and the denaturation rate. If you were to use an assay measuring activity for one second, it would give high activity at high temperatures, however if you were to use an assay measuring product formation over an hour, it would give you low activity at these temperatures.
Sources: en.wikipedia.org
In humans, replication protein A is the best-understood member of this family and is used in processes where the double helix is separated, including DNA replication, recombination, and DNA repair. These binding proteins seem to stabilize single-stranded DNA and protect it from forming stem-loops or being degraded by nucleases.
=== Identification of Protopodocarpoxylon === Protopodocarpoxylon is an extinct genus of conifer tracheophytes, now often found as fossilized woods. In a 2007 study, extraction and identification of biomarkers from fossil woods collected in south-central Poland allowed for the identification of the sample as Protopodocarpoxylon Eckhold. Samples of the wood were collected from clays and carbonate concretions then cleaned of contaminants before being pulverized, and the organics extracted. The extracts were derivatized with TMS and then subjected to gas chromatography-mass spectrometry (GC-MS) analysis. Multiple abietanes were detected in the analyzed samples, with ferruginol, sugiol, simonellite, and dehydroabietane present in all four of the samples tested. Sugiol and ferruginol were both detected as unaltered natural products. There was a dramatic difference in detected abundance of sugiol and ferruginol in samples that were more oxidized, but the biomarkers were still detectable in both cases. The unknown fossil wood samples were determined to contain aliphatic lipids (n-alkanols and n-alkanoic acids), diterpenoids (abietanes, labdanes, and totaranes), triterpenoids (lupane and hopane), and steroids. The presence of long chain n-alkanes, ferruginol, sugiol, and dehydroabietic acid were considered and the sample was determined to be a conifer plant, in either the Podocarpaceae, Cupressaceae, or Araucariaceae family.
== Career == Amyr Klink was the first person to row across the South Atlantic, leaving from Lüderitz, Namibia on 10 June 1984 and arriving 100 days later in Camaçari, Brazil, on 18 September 1984. He embarked on this journey without telling his father. His chronicles 100 Days Between Sea and Sky reports on the journey. The food portions in this trip were compacted into packages of freeze-dried food, especially designed for him by a food processing company in Brazil. Disney acquired the rights to make a film based on the events of Klink's journey. The 2026 biographical film 100 Dias was directed by Carlos Saldanha, and written by Elena Soarez. Brazilian actor Filipe Bragança portrays Amyr Klink. Klink has written seven books about his voyages, including Between Two Poles about his trip from Antarctica to the Arctic Pole, starting in 1989 and taking 642 days. Klink helped in the construction of the polar vessel used in this trip, named Paratii after the town of Paraty in the state of Rio de Janeiro, Brazil. In 1999 Klink completed a solo circumnavigation of Antarctica over 88 days. He was credited as the first to take the shortest and most dangerous route around Antarctica. In 2002, Klink has completed an experimental phase of one of his project, "A Trip to China", a trip around the world through a maritime path that had never been explored before: the Arctic Circle. The project's first phase was successfully accomplished between 30 January and 6 April 2002.
Sources: en.wikipedia.org
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.
It is commonly described as a 16-amino-acid peptide based on residues 176-191 of human growth hormone. Some sources vary in notation, so checking the stated sequence is useful.
It is not typically described as a standalone natural hormone. The sequence is derived from the C-terminal region of human growth hormone, but the synthetic peptide is a laboratory-made construct.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.